- Home
- KYMR vs PBF Comparison
KYMR vs PBF Comparison
Compare KYMR & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- PBF
- Stock Information
- Founded
- KYMR 2015
- PBF 2008
- Country
- KYMR United States
- PBF United States
- Employees
- KYMR N/A
- PBF N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- PBF Integrated oil Companies
- Sector
- KYMR Health Care
- PBF Energy
- Exchange
- KYMR Nasdaq
- PBF Nasdaq
- Market Cap
- KYMR 4.2B
- PBF 3.5B
- IPO Year
- KYMR 2020
- PBF 2012
- Fundamental
- Price
- KYMR $56.83
- PBF $29.95
- Analyst Decision
- KYMR Strong Buy
- PBF Hold
- Analyst Count
- KYMR 17
- PBF 13
- Target Price
- KYMR $61.65
- PBF $26.77
- AVG Volume (30 Days)
- KYMR 910.5K
- PBF 3.7M
- Earning Date
- KYMR 10-30-2025
- PBF 10-30-2025
- Dividend Yield
- KYMR N/A
- PBF 3.69%
- EPS Growth
- KYMR N/A
- PBF N/A
- EPS
- KYMR N/A
- PBF N/A
- Revenue
- KYMR $44,711,000.00
- PBF $30,275,300,000.00
- Revenue This Year
- KYMR $62.11
- PBF N/A
- Revenue Next Year
- KYMR N/A
- PBF $4.10
- P/E Ratio
- KYMR N/A
- PBF N/A
- Revenue Growth
- KYMR N/A
- PBF N/A
- 52 Week Low
- KYMR $19.45
- PBF $13.62
- 52 Week High
- KYMR $59.00
- PBF $34.29
- Technical
- Relative Strength Index (RSI)
- KYMR 65.68
- PBF 53.88
- Support Level
- KYMR $54.09
- PBF $29.01
- Resistance Level
- KYMR $59.00
- PBF $33.14
- Average True Range (ATR)
- KYMR 2.39
- PBF 1.66
- MACD
- KYMR 0.30
- PBF -0.35
- Stochastic Oscillator
- KYMR 80.00
- PBF 17.80
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.